Cost-Effectiveness Study of Criteria for Screening Cerebrospinal Fluid To Determine the Need for Herpes Simplex Virus PCR Testing
Open accessThe DOI matches its Crossref record; 9 of the 9 references it cites were found in a registry or an index.
Abstract
The absence of markers of inflammation in the cerebrospinal fluid (CSF) commonly predicts the absence of herpes simplex virus (HSV) central nervous system (CNS) infection. Consequently, multiple authors have proposed and validated criteria for deferring HSV PCR testing of CSF in immunocompetent hosts with normal CSF white blood cell and protein levels (≤5 cells/mm 3 and ≤50 mg/dl, respectively). Hosts are considered immunocompetent if they are ≥2 years old and have not had HIV or an organ transplant. Adoption of the criteria may erroneously exclude HSV-infected persons from a necessary diagnostic test or, alternatively, reduce the costs associated with HSV tests with minimal to no effect on patient care. Little is known about the cost-effectiveness of this approach. A decision analysis model was developed to evaluate the adoption of criteria for screening HSV tests of CSF. Estimates of input parameter values combined available literature with a multiyear multisite review at two of the largest health care systems in the United States. Adoption of criteria to screen for HSV test need proved cost-effective when less than 1 in 200 patients deferred from testing truly had an HSV CNS infection. Similar to prior studies, none of the deferred cases had HSV encephalitis (n= 3120). Adoption of these criteria in the United States would save an estimated $127 million ($95 million to $158 million [±25%]) annually. The model calculations remained robust to variation in test cost, prevalence of HSV infection, and random variation to study assumptions. The adoption of criteria to screen HSV PCR tests in CSF represents a cost-effective approach.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Tunkel, A. R., Glaser, C. A., Bloch, K. C., Sejvar, J. J., Marra, C. M., Roos, K. L., Hartman, B. J., Kaplan, S. L., Scheld, W. M., & Whitley, R. J. (2008) · Clinical Infectious Diseases · doi:10.1086/589747 · Cited by 1,193
Vidarabine versus Acyclovir Therapy in Herpes Simplex Encephalitis
Whitley, R. J., Alford, C. A., Hirsch, M. S., Schooley, R. T., Luby, J. P., Aoki, F. Y., Hanley, D., Nahmias, A. J., Soong, S.-J., & The NIAID Collaborative Antiviral Study Group* (1986) · New England Journal of Medicine · doi:10.1056/nejm198601163140303 · Cited by 896 · cited 1×
“Our hypothetical patient had an age of 50 years, based on published literature (17) and institutional experience, with a mean life expectancy of 31.”
Burden of encephalitis-associated hospitalizations in the United States, 1998-2010
Vora, N. M., Holman, R. C., Mehal, J. M., Steiner, C. A., Blanton, J., & Sejvar, J. (2014) · Neurology · doi:10.1212/wnl.0000000000000086 · Cited by 264 · cited 2×
“) As a comment in the new order set, clearly explain the indications for the order: (1) age of 2 years, (2) no HIV infection, and (3) no transplant-related immunosuppression.”
BackgroundBurden of encephalitis-associated hospitalizations in the United States, 1988-1997
Khetsuriani, N., Holman, R. C., & Anderson, L. J. (2002) · Clinical Infectious Diseases · doi:10.1086/341301 · Cited by 200 · cited 3×
“A 9-year review of encephalitis-associated hospitalizations listed HSV as one of the most common known pathogens, which accounted for 2,100 annual hospitalizations (2).”
BackgroundAurelius, E., Franzen-Rohl, E., Glimaker, M., Akre, O., Grillner, L., Jorup-Ronstrom, C., Studahl, M., & the HSV-2 Meningitis Study Group (2012) · Clinical Infectious Diseases · doi:10.1093/cid/cis031 · Cited by 86 · cited 2×
“For example, we did not consider ACV treatment to modify the outcomes of HSV meningitis (11, 15).”
BackgroundMethodSimko, J. P., Caliendo, A. M., Hogle, K., & Versalovic, J. (2002) · Clinical Infectious Diseases · doi:10.1086/341979 · Cited by 64
Validation of laboratory screening criteria for herpes simplex virus testing of cerebrospinal fluid
Hanson, K. E., Alexander, B. D., Woods, C., Petti, C., & Reller, L. B. (2007) · Journal of Clinical Microbiology · doi:10.1128/jcm.01950-06 · Cited by 56 · cited 3×
“Two other studies found no exceptions in 1,518 and 268 completed tests (7, 8).”
BackgroundResultHaukali Omland, L., Faber Vestergaard, B., & Heugh Wandall, J. (2008) · Scandinavian Journal of Infectious Diseases · doi:10.1080/00365540701509881 · Cited by 44
Wilen, C. B., Monaco, C. L., Hoppe-Bauer, J., Jackups, R., Bucelli, R. C., & Burnham, C.-A. D. (2015) · Journal of Clinical Microbiology · doi:10.1128/jcm.03161-14 · Cited by 27
Cited by
Messacar, K., Palmer, C., Gregoire, L., Elliott, A., Ackley, E., Perraillon, M. C., Tyler, K. L., & Dominguez, S. R. (2022) · The Journal of Pediatrics · doi:10.1016/j.jpeds.2022.02.002 · Cited by 34
Messacar, K., Gaensbauer, J. T., Birkholz, M., Palmer, C., Todd, J. K., Tyler, K. L., & Dominguez, S. R. (2020) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2020.115085 · Cited by 20
Albert, E., Alberola, J., Bosque, M., Camarena, J. J., Clari, M. Á., Domínguez Márquez, M. V., Gil-Fortuño, M., Gimeno, A., Nogueira, J. M., Ocete, M. D., et al. (2019) · Journal of Clinical Microbiology · doi:10.1128/jcm.01719-18 · Cited by 14
“Hauser and colleagues (6) showed that application of the Reller criteria for CSF HSV PCR testing is cost-effective if fewer than 1 in 200 patients deferred from PCR in fact test positive for HSV CNS infection.”
BackgroundNgo Nsoga, M. T., Pérez-Rodriguez, F. J., Mamin, A., L’Huillier, A. G., Cherkaoui, A., Kaiser, L., & Schibler, M. (2023) · Microbiology Spectrum · doi:10.1128/spectrum.03179-22 · Cited by 11
“Some studies confirmed the cost-effectiveness of these criteria (17, 18).”
Background
Metadata
- Authors
- Hauser, R. G., Campbell, S. M., Brandt, C. A., & Wang, S.
- Venue
- Journal of Clinical Microbiology
- Publisher
- American Society for Microbiology
- Published
- 2017-05
- Volume
- 55
- Issue
- 5
- Pages
- 1566-1575
- ISSN
- 0095-1137 (ISSN-L)
- 1098-660X
- OpenAlex
- W2599218850
- Cited by
- 15
- References
- 9
- FWCI
- 1.67
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Cost-Effectiveness Study of Criteria for Screening Cerebrospinal Fluid To Determine the Need for Herpes Simplex Virus PCR Testing. https://app.cochat.ai/papers/10.1128/jcm.00119-17
- The paper
- Hauser, R. G., Campbell, S. M., Brandt, C. A., & Wang, S. (2017). Cost-Effectiveness Study of Criteria for Screening Cerebrospinal Fluid To Determine the Need for Herpes Simplex Virus PCR Testing. Journal of Clinical Microbiology. https://doi.org/10.1128/jcm.00119-17
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.